What is the appropriate dose of ondansetron (Zofran) for a child experiencing vomiting?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The appropriate dose of ondansetron for a child experiencing vomiting is 0.15 mg/kg/dose, with a maximum dose of 16 mg/dose, as recommended for children aged 6 months and older. This dose is supported by the international consensus guidelines for the diagnosis and management of food protein-induced enterocolitis syndrome, as outlined in the Journal of Allergy and Clinical Immunology 1.

Key Considerations

  • The dose of ondansetron should be calculated based on the child's weight, with a maximum dose of 16 mg/dose.
  • Ondansetron can be administered intramuscularly or intravenously, depending on the severity of the symptoms and the child's age.
  • The medication should be used with caution and under medical supervision, especially in children with a history of severe reactions or those who are at risk of dehydration.

Administration and Monitoring

  • Ondansetron can be administered every 4-6 hours as needed, with monitoring for resolution of symptoms and potential side effects.
  • It is essential to ensure the child is well-hydrated and to monitor for signs of dehydration, such as decreased urine output, dry mouth, and dizziness.
  • Parents or caregivers should be instructed on how to administer the medication, monitor for side effects, and seek medical attention if symptoms persist or worsen.

Special Considerations

  • Children under 6 months of age may require alternative treatments or closer medical supervision due to the potential risks associated with ondansetron.
  • The use of ondansetron in children with severe FPIES reactions should be carefully considered, and food challenges should be performed in a hospital or monitored setting with immediate availability of intravenous resuscitation, as recommended by the guidelines 1.

From the FDA Drug Label

04 to 0.87 mg per kg (total dose of 2. 16 mg to 12 mg) followed by the administration of oral doses of ondansetron tablets ranging from 4 to 24 mg daily for 3 days. In 2 trials the response rates to ondansetron tablets 4 mg three times a day in patients younger than 12 years was similar to ondansetron tablets 8 mg three times daily in patients 12 to 18 years.

The appropriate dose of ondansetron (Zofran) for a child experiencing vomiting is:

  • 0.04 to 0.87 mg per kg (total dose of 2.16 mg to 12 mg) for the initial dose, followed by
  • 4 to 24 mg daily for 3 days, with the exact dosing depending on the child's age and weight. For children younger than 12 years, 4 mg three times a day may be used, while for children 12 to 18 years, 8 mg three times daily may be used 2.

From the Research

Appropriate Dose of Ondansetron for Children Experiencing Vomiting

The appropriate dose of ondansetron for children experiencing vomiting can vary depending on the specific condition and the route of administration.

  • For oral administration, a dose of 0.1 mg/kg to 0.2 mg/kg is recommended, with a maximum dose of 4 mg 3, 4.
  • For parenteral administration, a dose of 0.15 mg/kg is recommended, with a maximum dose of 4 mg 3.
  • In the case of gastroenteritis, a single dose of 0.1 mg/kg to 0.2 mg/kg has been shown to be effective in reducing vomiting and improving oral rehydration 4, 5.
  • In the case of chemotherapy-induced vomiting, a dose of 0.15 mg/kg to 0.2 mg/kg has been shown to be effective in preventing emesis 6.
  • In the case of post-operative vomiting, a dose of 0.1 mg/kg to 0.15 mg/kg has been shown to be effective in preventing emesis 6, 7.

Key Considerations

  • The dose of ondansetron should be individualized based on the specific needs of the child and the severity of the vomiting.
  • The use of ondansetron should be guided by the clinical judgment of a healthcare professional.
  • Ondansetron should be used in conjunction with other treatments, such as oral rehydration therapy, to manage vomiting and prevent dehydration.
  • The efficacy and safety of ondansetron in children have been established in several studies, including randomized controlled trials 3, 4, 5, 6, 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of a child with vomiting.

Indian journal of pediatrics, 2013

Research

Oral ondansetron for paediatric gastroenteritis in primary care: a randomised controlled trial.

The British journal of general practice : the journal of the Royal College of General Practitioners, 2021

Research

Emergency department treatment of viral gastritis using intravenous ondansetron or dexamethasone in children.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.